- Home
- ARWR vs PACS Comparison
ARWR vs PACS Comparison
Compare ARWR & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- PACS
- Stock Information
- Founded
- ARWR 2003
- PACS 2013
- Country
- ARWR United States
- PACS United States
- Employees
- ARWR N/A
- PACS N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- PACS
- Sector
- ARWR Health Care
- PACS
- Exchange
- ARWR Nasdaq
- PACS Nasdaq
- Market Cap
- ARWR 1.8B
- PACS 2.0B
- IPO Year
- ARWR 1993
- PACS 2024
- Fundamental
- Price
- ARWR $17.64
- PACS $12.59
- Analyst Decision
- ARWR Buy
- PACS Strong Buy
- Analyst Count
- ARWR 8
- PACS 7
- Target Price
- ARWR $43.71
- PACS $34.29
- AVG Volume (30 Days)
- ARWR 1.6M
- PACS 808.9K
- Earning Date
- ARWR 08-07-2025
- PACS 08-11-2025
- Dividend Yield
- ARWR N/A
- PACS N/A
- EPS Growth
- ARWR N/A
- PACS 82.80
- EPS
- ARWR N/A
- PACS 0.68
- Revenue
- ARWR $545,209,000.00
- PACS $3,558,953,000.00
- Revenue This Year
- ARWR $22,384.93
- PACS $28.62
- Revenue Next Year
- ARWR N/A
- PACS $16.94
- P/E Ratio
- ARWR N/A
- PACS $18.37
- Revenue Growth
- ARWR 1436.97
- PACS 205.08
- 52 Week Low
- ARWR $9.57
- PACS $8.28
- 52 Week High
- ARWR $30.41
- PACS $43.92
- Technical
- Relative Strength Index (RSI)
- ARWR 68.77
- PACS N/A
- Support Level
- ARWR $18.10
- PACS N/A
- Resistance Level
- ARWR $19.07
- PACS N/A
- Average True Range (ATR)
- ARWR 0.79
- PACS 0.00
- MACD
- ARWR 0.22
- PACS 0.00
- Stochastic Oscillator
- ARWR 85.75
- PACS 0.00
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About PACS PACS Group Inc. Common Stock
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.